StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
GWTI

Greenway Technologies, Inc.

GWTI OTC Industrial Organic Chemicals EDGAR ↗
$0.02
+0.00 +28.15%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$8.04M
Revenue (TTM) ⓘ
$24.6K
Net income (TTM) ⓘ
-$1.34M
EPS (TTM) ⓘ
$0.00
P/E ratio ⓘ
—
Dividend yield ⓘ
—
Free cash flow ⓘ
—
Cash ⓘ
$461
Total assets ⓘ
$3.40K
Gross margin ⓘ
18.6%
52-week range ⓘ
$0.01 – $0.07

AI briefing

from the latest 10-K, 10-Q and 8-K events

Greenway Technologies is a pre-revenue development-stage company commercializing proprietary gas-to-liquids Syngas conversion systems built around its G-Reformer unit.

What they do

Greenway Technologies researches and develops proprietary gas-to-liquids (GTL) synthesis gas conversion systems and micro-plants, realized today in its first commercial G-Reformer unit, which converts natural gas into Syngas. Combined with a Fischer-Tropsch reactor and catalyst, the system is designed to produce gasoline, diesel, jet fuel, methanol and other high-value chemicals, and the company is also developing G-Reformers for hydrogen production. The technology is owned through its wholly-owned subsidiary Greenway Innovative Energy (GIE) and is based on a process called Fractional Thermal Oxidation.

Revenue drivers

  • GTL technology licensing and plant sales — The stated objective is to become a direct and licensed producer of renewable GTL synthesized gasoline, diesel, jet fuel, high-value chemicals, methanol and hydrogen; no current revenue from this line is disclosed in the excerpts.
  • G-Reformer unit production — The company produces G-Reformer units, the critical Syngas-generation component of its system, for both fuel and hydrogen applications; no revenue figures for this line appear in the excerpts.
  • High-value chemicals and alcohols — The company states that its G-Reformer catalyst reactor and FT technology can also extract chemicals including n-Hexane, n-Heptane, n-Octane, n-Decane, n-Dodecane and Tridecane, plus ethanol and methanol; it identifies worldwide industrial demand for these outputs but cites no sales.

Recent performance

Annual net losses have persisted for at least five years: $1.7M in 2021, $1.5M in 2022, $1.6M in 2023, $1.5M in 2024 and $2.0M in 2025, with diluted EPS reported as $0 or $(0.01). Operating cash flow has been negative every year, including $(791,906) in 2021, $(496,654) in 2022, $(302,663) in 2023, $(444,223) in 2024 and $(710,289) in 2025. The last reported annual revenue figures are from 2012 ($59,257), 2013 ($15,479) and 2014 ($24,581); recent quarterly revenue reported in the data is $0.00. At March 31, 2026 the balance sheet showed total assets of $51,375, cash and equivalents of $7,271, and shareholder equity of negative $14.5M.

Strategy

The company's stated objective is to become a material direct and licensed producer of renewable GTL synthesized gasoline, diesel, jet fuel, high-value chemicals, methanol and hydrogen, with a near-term focus on U.S. market opportunities. It holds issued U.S. patents on its GTL technology, including Patent 8,574,501 B1, 8,795,597 B2 and 10,633,594 B1, and has pending domestic and international applications. An exclusive worldwide patent licensing agreement with The University of Texas at Arlington covers GWTI's natural gas reforming technologies developed under its sponsored research agreement. In August 2012 the company acquired 100% of Greenway Innovative Energy, which owns the patents and trade secrets behind the technology.

Risks

  • Going concern — The 10-Q states that recurring net losses and inability to generate sufficient cash flows to meet obligations and sustain operations raise substantial doubt about the ability to continue as a going concern.
  • Need for additional capital — The 10-K states that executing the production, sale or licensing of GTL technology may depend on raising additional debt or equity capital on terms that are uncertain and outside the company's control.
  • Pre-revenue operating history — The company describes itself as a development-stage, pre-revenue company with a limited operating history and insufficient experience regarding actual revenues from its GTL technology.
  • History of losses — The company has incurred significant operating losses since inception and says there can be no assurance it will earn net income or generate positive cash flow in the future.

Outlook

Management's discussion states that the company expects to need additional capital to fund operations and execute its GTL business strategy, and it identifies the going-concern doubt as the central financing issue. The stated near-term focus is U.S. market opportunities for GTL-synthesized fuels and hydrogen. The company reports no revenue outlook or guidance figures in the excerpts; reported recent quarterly revenue is $0.00.

Recent SEC filings

40 most recent
Annual, quarterly & current reports